Allergan Aesthetics, an AbbVie company, is the world's largest dedicated medical aesthetics business, bringing together some of the most recognised brands in the industry under a single portfolio. Operating across facial injectables, body contouring, skincare, and regenerative medicine, the division combines decades of clinical heritage with one of the broadest product ranges in the sector.
BOTOX Cosmetic is the flagship product and the world's best-known prescription neuromodulator for aesthetic use. Alongside it, the Juvederm collection of hyaluronic acid fillers represents one of the most extensively studied dermal filler ranges globally, covering volumisation, contouring, and fine-line correction across multiple facial zones. These two pillars make Allergan Aesthetics the dominant force in facial injectables worldwide.
The portfolio extends well beyond injectables. CoolSculpting, the non-invasive fat-reduction technology based on cryolipolysis, is a market-defining platform with a large installed base across clinics and medical spas globally. SkinMedica, the company's medical-grade skincare brand, addresses skin health from a science-led perspective and is widely distributed through physician channels. The addition of Skinvive, a skin-quality injectable, reflects continued investment in expanding the injectable category beyond traditional volumisation.
Allergan Aesthetics operates as a global division of AbbVie, which acquired Allergan in 2020 in one of the largest pharmaceutical transactions of that decade. The aesthetics business benefits from AbbVie's global commercial infrastructure, regulatory expertise, and R&D capabilities while maintaining a focused identity within the medical aesthetics market. Its customer base includes plastic surgeons, dermatologists, aesthetic physicians, and trained nurse injectors across more than 100 countries.
Training and medical education form a significant part of the company's engagement with practitioners, with the Allergan Medical Institute providing accredited education programmes for healthcare professionals seeking to build or advance their aesthetics practice. This emphasis on professional development supports product safety and underpins the company's positioning as a partner to the clinical community rather than solely a product supplier.
Further information is available at allerganaesthetics.com.